We are live on
!
Find out more
SAM
Strategy Asset Managers Portfolio holdings
AUM
$650M
Turnover
21.36%
1-Year Est. Return
25.51%
This Fund
S&P 500
This Quarter
Est. Return
+1.74%
1 Year Est. Return
+25.51%
3 Year Est. Return
+115.5%
5 Year Est. Return
+130.94%
10 Year Est. Return
+375.79%
AUM
$446M
AUM Growth
+$6.08M
(+1.4%)
Cap. Flow
+$2.55M
Cap. Flow
% of AUM
0.57%
Top 10 Holdings %
Top 10 Hldgs %
25.06%
Holding
152
New
22
Increased
42
Reduced
42
Closed
27
Avg Time Held
2
years
Top 10 Avg Time Held
0.9
years
Top 20 Avg Time Held
2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microchip Technology
MCHP
|
+$8.22M |
| 2 |
AT&T
T
|
+$2.88M |
| 3 |
Hologic
HOLX
|
+$2.66M |
| 4 |
Xylem
XYL
|
+$2.66M |
| 5 |
Acuity Brands
AYI
|
+$2.62M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Anywhere Real Estate
HOUS
|
+$4.88M |
| 2 |
NVIDIA
NVDA
|
+$3.56M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$3.33M |
| 4 |
Hormel Foods
HRL
|
+$2.97M |
| 5 |
LVLT
Level 3 Communications Inc
LVLT
|
+$2.77M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.58% |
| 2 | Industrials | 15.73% |
| 3 | Technology | 14.59% |
| 4 | Consumer Staples | 13.11% |
| 5 | Financials | 10.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Microsoft
MSFT
$4.01T
| $14.5M | 3.25% |
251,557
-3,104
| -1% | -$175K |
2013 Q2
13 quarters
|
|
2
Lockheed Martin
LMT
$123B
| $11.6M | 2.61% |
48,518
-1,549
| -3% | -$388K |
2013 Q2
13 quarters
|
|
3
Johnson & Johnson
JNJ
$610B
| $11.2M | 2.52% |
95,046
-1,843
| -2% | -$224K |
2013 Q2
13 quarters
|
|
4
Merck
MRK
$358B
| $10.8M | 2.42% |
181,328
-2,756
| -1% | -$161K |
2013 Q2
13 quarters
|
|
5
Cisco
CSCO
$433B
| $10.8M | 2.41% |
339,423
-323
| -0.1% | -$9.94K |
2013 Q2
13 quarters
|
|
6
DuPont de Nemours
DD
$17.8B
| $10.7M | 2.41% |
81,851
-276
| -0.3% | -$36.8K |
2013 Q4
11 quarters
|
|
7
Altria Group
MO
$123B
| $10.6M | 2.39% |
168,407
-2,442
| -1% | -$162K |
2013 Q2
13 quarters
|
|
|
8
Microchip Technology
MCHP
$40.3B
| $10.6M | 2.38% |
340,996
+282,718
| +485% | +$8.22M |
2013 Q2
13 quarters
|
|
9
Honeywell
HON
$66.7B
| $10.5M | 2.35% |
99,940
-2,159
| -2% | -$226K |
2013 Q2
13 quarters
|
|
10
JPMorgan Chase
JPM
$891B
| $10.4M | 2.33% |
156,123
-784
| -0.5% | -$51.1K |
2013 Q2
13 quarters
|
|
11
American International
AIG
$41.4B
| $10.2M | 2.29% |
172,466
+384
| +0.2% | +$21.9K |
2014 Q1
10 quarters
|
|
12
Pfizer
PFE
$168B
| $10.1M | 2.27% |
314,727
+754
| +0.2% | +$25.2K |
2013 Q2
13 quarters
|
|
13
Procter & Gamble
PG
$365B
| $9.99M | 2.24% |
111,343
-1,207
| -1% | -$105K |
2013 Q2
13 quarters
|
|
14
General Dynamics
GD
$91.2B
| $9.84M | 2.21% |
63,418
+366
| +0.6% | +$54.6K |
2015 Q4
3 quarters
|
|
15
United Parcel Service
UPS
$83.2B
| $9.68M | 2.17% |
88,516
-777
| -0.9% | -$84.9K |
2013 Q4
11 quarters
|
|
16
Diageo
DEO
$52.3B
| $9.25M | 2.07% |
79,697
+581
| +0.7% | +$66.4K |
2015 Q3
4 quarters
|
|
17
Oracle
ORCL
$408B
| $9.02M | 2.02% |
229,505
-1,429
| -0.6% | -$58.2K |
2013 Q2
13 quarters
|
|
18
Walt Disney
DIS
$191B
| $8.97M | 2.01% |
96,577
-660
| -0.7% | -$63.2K |
2013 Q2
13 quarters
|
|
19
Loews
L
$22.2B
| $8.65M | 1.94% |
210,239
-2,203
| -1% | -$90.5K |
2013 Q2
13 quarters
|
|
20
CVS Health
CVS
$118B
| $8.55M | 1.92% |
96,111
-1,308
| -1% | -$123K |
2013 Q2
13 quarters
|
|
|
RDS.A
21
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $8.32M | 1.87% |
172,067
+8,509
| +5% | +$416K |
2013 Q2
13 quarters
|
|
|
BHI
22
DELISTED
Baker Hughes
BHI
| $7.63M | 1.71% |
151,155
+4,052
| +3% | +$195K |
2013 Q2
13 quarters
|
|
23
Ford
F
$49.1B
| $7.49M | 1.68% |
620,515
-16,120
| -3% | -$203K |
2013 Q4
11 quarters
|
|
24
Bristol-Myers Squibb
BMY
$124B
| $7.28M | 1.63% |
134,928
+4,983
| +4% | +$320K |
2013 Q2
13 quarters
|
|
25
Teva Pharmaceutical Industries Limited
TEVA
$47.9B
| $7.23M | 1.62% |
157,143
+112
| +0.1% | +$5.84K |
2013 Q2
13 quarters
|
|
Similar funds
BI
GCM
GWAG
BRIM
PPW
OCAM
AAS
TAWM
Strategy Asset Managers's Q3 2016 Portfolio in Review
As of Q3 2016, Strategy Asset Managers held 152 positions worth $446M, up 1.4% from $440M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Strategy Asset Managers's Q3 2016 filing shows 22 new, 42 increased, 42 reduced and 27 closed positions. Its largest new stake was Hologic: 70,567 shares worth $2.74M. The largest sale was Anywhere Real Estate, an estimated $4.88M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Industrials and Technology.
- Strategy Asset Managers's largest Q3 2016 buy was Hologic: 70,567 shares worth $2.74M.
- Strategy Asset Managers added most to Microchip Technology in Q3 2016, an estimated $8.22M increase.
- Strategy Asset Managers's biggest Q3 2016 reduction was Anywhere Real Estate, cutting an estimated $4.88M.
- Strategy Asset Managers fully exited NVIDIA in Q3 2016, selling an estimated $3.56M.
- Strategy Asset Managers's ten largest holdings make up 25% of its $446M portfolio in Q3 2016.
- Strategy Asset Managers opened 22 new positions and closed 27 in Q3 2016.
- Strategy Asset Managers's portfolio value rose 1.4% quarter-over-quarter to $446M.
Based on Strategy Asset Managers's 13F filing for Q3 2016, filed 31 Oct 2016.